NCT01273727View on ClinicalTrials.gov

Ozurdex for Macular Edema Post Membrane Peeling

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Epiretinal MembraneCellophane MaculopathyMacular EdemaRetinal Edema

Interventions

DRUG

Dexamethasone

intravitreal implant 0.7 mg 6 month duration

DRUG

dexamethasone

intravitreal implant 0.7 mg duration 6 months

Trial Locations (1)

10011

Retina Specialists PC, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Retina Specialists, PC

OTHER